Equities research analysts at Zacks Research lowered their Q2 2025 earnings estimates for Elevance Health in a research ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurosense Therapeutics Ltd. (NRSN – Research Report), ...

A collection of prominent healthcare interests were among the donors to President Donald Trump’s inaugural fund. | The pharma ...

The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...

Pre-earnings options volume in Oscar Health (OSCR) is 4.7x normal with calls leading puts 8:1. Implied volatility suggests the market is ...

The portfolio’s return was -3.89% (net) for the reporting period vs. MSCI World Index that returned -0.16% for the same ...

The portfolio’s return was -3.87% (net) for the reporting period vs. MSCI World Index that returned -0.16% for the same ...